Cannabis Sativa Inc. was founded in January 2014 and started trading on the OTC Markets (Ticker: CBDS) in November 2014. CBDS has a track record of success in the development and distribution of hemp-based nutraceutical and pharmaceutical products. The company was the first to gain approval in the U.S. for an over-the-counter topical cannabinoid product with its flagship product, HiTonic.
